Health Care: Drugs

Tekmira Pharmaceuticals Corp (TKMR: NASDAQ)

$18.75 n/a | n/a%
04/24/15 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 18.97
52 Week High 29.93
52 Week Low 8.86
Avg. Daily Vol. (Mil) 0.77
Beta (3 year) -0.66
Share Related Items
Mkt Cap (Mil) 883.39
Shares Out (Mil) 46.57
Float (Mil) 21.83
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 5.60
Current Ratio 5.80
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 59.08
Price/Book 10.03
Price/Cash Flow -23.10
Per Share Data
Earnings -1.80
Sales 0.32
Book Value 1.89
Cash Flow -0.82
Business Summary
Tekmira Pharmaceuticals Corp is abiopharmaceutical business engaged in advancing novel RNA interference therapeutics and discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection.
General Information
100 - 8900 Glenlyon Parkway
Burnaby, BC V5J 5J8
www.tekmira.com
Industry : Drugs
Sector: Health Care
Employees: 103
CEO: Dr. Mark J. Murray,PhD
Short Interest
Current Month (Mil) 3.76
Previous Month (Mil) 3.64
Short Interest Ratio (Days) 3.90
Management Effectiveness
Return on Equity n.a.
Return on Assets -32.90
Return on Investments -44.10
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter